Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.5 mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
21 mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
31mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
5Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[10] 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
6Budesonide (6 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
7Budesonide (9 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
8Budesonide 0.5 mg compresse orodispersibili
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
9Budesonide 0.5 mg orodispersible tablets
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
10Budesonide 0.5mg orodispersible tablet twice daily
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
11Budesonide 1 mg compresse orodispersibili
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
12Budesonide 1 mg orodispersible tablets
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
13Budesonide 1 mg orodispersible tablets (BUL 1 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
14Budesonide 1mg orodispersible tablet twice daily
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
15Budesonide 2 mg orodispersible tablets (BUL 2 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
16Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
17Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
18Budesonide 9 mg capsules, hard (BUX-PV)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
19Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
20Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
21Budesonide [0.4mg/ml] viscous suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
22Budesonide Gel
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
23Budesonide MMX
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
24Budesonide MMX 6 mg Tablet
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
25Budesonide MMX®
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
26Budesonide MMX® 6 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
27Budesonide MMX® 9 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
28Budesonide oral suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
29Budesonide oral suspension [0.2 mg/ml]
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
30Budesonide Orodispersible Tablets (Jorveza)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
31Budesonide plus Prevacid
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
32Budesonide-formoterol single inhaler
(D00246)		[2] Budesonide,
Formoterol		[3] Budesonide (D00246),
Formoterol fumarate ,
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
33Budesonide-MMX
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
34Budesonide-MMX®
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
35Budesonide-MMX® 6 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
36Budesonide-MMX® 9 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
37Budesonide-MMX™
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
38Budesonide/formoterol
(D00246)		[2] Budesonide,
Formoterol		[3] Budesonide (D00246),
Formoterol fumarate ,
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228 💬
39Combination Oral Budesonide and Rectal Hydrocortisone
(D00246)		[2] Budesonide,
Hydrocortisone		[2] Hydrocortisone ,
Budesonide (D00246) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
40Compressa effervescente 0,5 mg di budesonide per uso orodispersibile
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
41Compressa effervescente 1 mg di budesonide per uso orodispersibile
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42Formoterol/Budesonide
(D00246)		[2] Budesonide,
Formoterol		[3] Budesonide (D00246),
Formoterol fumarate ,
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228 💬
43Gut-directed budesonide and SoC
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
44High Dose Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
45High dose budesonide rectal foam
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
46High dose budesonide suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
47High dose budesonide tablet
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
48High dose of budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
49Inhaled/swallowed budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
50Low Dose Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
51Low dose budesonide rectal foam
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
52Low dose budesonide tablet
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
53Methylprednisolone or budesonide
(D00246)		[2] Budesonide,
Methylprednisolone		[3] Budesonide (D00246),
Methylprednisolone ,
Methylprednisolone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
54Oral Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 97, 98 💬
55Oral Budesonide Suspension (MB-9)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
56Oral Budesonide Suspension (OBS)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
57Oral Viscous Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
58Oral Viscous Budesonide (OVB)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
59Probiotics combined with enteric-coated budesonide capsule
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
60The IMP is authorized but for a different indication and route of administration. IMP will be budesonide in nebulized suspension but for oral administration. The idea is local action, low dose available in this formula and very low bioavailability.
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
61Viscous/swallowed budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬